D. E. SHAW & CO L.P. 13D and 13G filings for Viridian Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-14 4:05 pm Purchase |
2021-12-31 | 13G | Viridian Therapeutics, Inc. VRDN |
D. E. SHAW & CO L.P. | 764,613 3.500% |
44,240 (+6.14%) |
Filing |
| 2021-06-01 4:02 pm Purchase |
2021-05-20 | 13G | Viridian Therapeutics, Inc. VRDN |
D. E. SHAW & CO L.P. | 720,373 8.500% |
248,679 (+52.72%) |
Filing |
| 2021-05-10 4:04 pm Purchase |
2021-04-29 | 13G | Viridian Therapeutics, Inc. VRDN |
D. E. SHAW & CO L.P. | 471,694 6.500% |
471,694 (New Position) |
Filing |